Renounces their rights? It’s licensing the rights to China to the partnership in China. It’s great that the data can be used with out fda as well as emea with Generex not responsible for the costs of those studies. They’ll be US studies as well and hopefully it’s all rolling soon. Hey, one partner is the Chinese CDC.